ENX-104 MAD Study for Participants With Major Depressive Disorder With Anhedonia (aMDD)

Clinical trial NCT07253324 · COMPLETED

Trial details

NCT number: NCT07253324
Sponsor: Engrail Therapeutics INC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2025-02-17
Primary completion: 2025-11-26
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.